ArticleEuropean journal of medical research2025
Zoster-associated pain: pretreatment time interval is inversely associated with pulsed radiofrequency effectiveness in a retrospective mono-institutional analysis.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPulsed radiofrequency (PRF) is an effective treatment for herpes zoster-associated pain (ZAP), the optimal time to perform the PRF treatment remains unclear. This study aimed to explore this relationship and determine the optimal timing for PRF intervention.
methodsThis research conduct a single-center retrospective cohort study in China. 303 patients who received PRF treatment for ZAP were followed up for 3 months. The primary endpoints were numerical rating scale (NRS) score and NRS reduction rate. Multiple assessment scales were used to evaluate pain and symptoms. Cox regression analysis and restricted cubic spline analysis were performed to examine the relationship between pre-treatment time interval (PTI) and outcomes.
results69.9% achieved positive outcomes after PRF treatment. The incidence of positive outcomes decreased from 82.14% in the lowest PTI quartile to 48% in the highest. After adjusting for confounding factors, prolonged PTI was associated with an increased risk of negative PRF outcomes. Restricted Cube Spline (RCS) analysis revealed a non-linear relationship between PTI and treatment outcomes, with the risk of negative outcomes increasing rapidly initially before plateauing.
conclusionsThe optimal timing for PRF treatment was determined to be within 1.5 months of herpes onset. Single-center results may be influenced by institution-specific practices and physician-related biases, and longer follow-up period is necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.